Literature DB >> 21696523

Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease.

Ludovico Abenavoli1.   

Abstract

Entities:  

Year:  2011        PMID： 21696523     DOI： 10.1111/j.1872-034X.2011.00823.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN： 1386-6346            Impact factor:   4.288


× No keyword cloud information.
  2 in total

1.  Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.

Authors:  Ludovico Abenavoli; Natasa Milic; Francesco Capasso
Journal:  Endocrine       Date:  2012-12       Impact factor: 3.633

Review 2.  Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.

Authors:  Camila Ribeiro de Avelar; Emile Miranda Pereira; Priscila Ribas de Farias Costa; Rosângela Passos de Jesus; Lucivalda Pereira Magalhães de Oliveira
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.